GD2 synthase: A new molecular marker for detecting neuroblastoma

Cancer

Volumn 92, Issue 4, 2001, Pages 924-931

  Piccolo, Maria Serena Lo ^a   Cheung, Nai Kong V ^a   Cheung, Irene Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemiluminescence; Histology; Immunofluorescence; Molecular detection; RT PCR

Indexed keywords

GANGLIOSIDE GD2; SYNTHETASE; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; BONE MARROW; CANCER DIAGNOSIS; CELL LINE; CHEMOLUMINESCENCE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE MARROW; CHEMILUMINESCENT MEASUREMENTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM STAGING; NEUROBLASTOMA; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035880694     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010815)92:4<924::AID-CNCR1402>3.0.CO;2-O     Document Type: Article

References (36)

1. Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage W neuroblastoma: A Children's Cancer Group study
2. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma
3. Detection of metastatic neuroblastoma in bone marrow: When is routine marrow histology insensitive?
4. Detection and management of bone marrow micrometastases in breast cancer
5. Detection of minimal disease in patients with solid tumors
6. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year
7. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction
8. Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma
9. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
10. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601
11. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
12. Molecular detection of GAGE expression in peripheral blood and bone marrow: Utility as a tumor marker for neuroblastoma
13. Frequent expression of MAGE and BAGE genes by neuroblastoma
14. MAGE-1 and MAGE-3 or -6 expression in neuroblastoma-related pediatric solid tumors
15. Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma
16. Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma
17. Genomic organization and chromosomal assignment of the human beta 1, 4-N-acetylgalactosaminyltransferase gene. Identification of multiple transcription units
18. Heterogeneity in the expression pattern of two ganglioside synthase genes during mouse brain development
19. GA2/GM2/ GD2 synthase localizes to the trans-Golgi network of CHO-K1 cells
20. Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides
21. Enhanced expression of GM2/GD2 synthase mRNA in human gastrointestinal cancer
22. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies
23. Expression of GD2 ganglioside by untreated primary human neuroblastomas
24. Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma
25. Assessment of messenger RNA of beta 1,4-N-acetylgalactosaminyl transferase as a molecular marker for metastatic melanoma
26. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
27. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: A multivariate analysis in 218 patients treated in a single institution
28. Clinical prognostic factors in 1277 patients with neuroblastoma: Results of the European Neuroblastoma Study Group "survey" 1982-1992
29. High-sensitivity immunocytologic analysis of neuroblastoma cells in paired blood and marrow samples
30. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA
31. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells
32. Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma
33. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis
34. Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue
35. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas
36. Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers